Vaccination against SARS-CoV-2 in Patients with Inflammatory Bowel Diseases: Where Do We Stand?

por Phil-Robin Tepasse, Richard Vollenberg, Tobias Max Nowacki
Publicado 2021

Indications of Persistent Glycocalyx Damage in Convalescent COVID-19 Patients: A Prospective Multicenter Study and Hypothesis

por Richard Vollenberg, Phil-Robin Tepasse, Kevin Ochs, Martin Floer, Markus Strauss, Florian Rennebaum, Iyad Kabar, Alexandros Rovas, Tobias Nowacki
Publicado 2021

Persistent symptoms and lab abnormalities in patients who recovered from COVID-19

por Julian Varghese, Sarah Sandmann, Kevin Ochs, Inga-Marie Schrempf, Christopher Frömmel, Martin Dugas, Hartmut H. Schmidt, Richard Vollenberg, Phil-Robin Tepasse
Publicado 2021